Thryv Holdings recently saw its consensus analyst price target fall significantly, dropping from $19.50 to $13.00. This notable decline comes as experts reassess the company’s near-term prospects in ...

Hundreds of small business owners and entrepreneurs gathered in Scottsdale last month to talk strategy at the Grow2025 ...

Thryv® (NASDAQ: THRY), Australia and New Zealand’s provider of the leading small business marketing and sales software platform, has announced a new partnership with Physiotherapy New Zealand (PNZ), ...

This commitment is quantifiable: 62 percent of small businesses expect to spend at least $1,000 on AI in the coming year, ...

Thryv Holdings, Inc. stock dips on slowed growth, but management targets strong SaaS revenue by 2030. Click for more on THRY stock prospects.

Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing a series of novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited cardiac arrhythmias, cardiometabolic ...

Thryv® Holdings, Inc. (NASDAQ:THRY), provider of the leading small business marketing and sales software platform, has launched a tailored growth marketing solution for home services businesses ...

Amid global market volatility, TipRanks offers valuable tools to guide investors. One of the most powerful is the Smart Score ...

Thryv® Holdings, Inc. (NASDAQ:THRY), provider of the leading small business marketing and sales software platform, has launched a tailored growth marketing solution for home services businesses ...

William Blair analyst Arjun Bhatia downgraded Thryv Holdings (THRY) to Market Perform from Outperform without a price target The firm cites the ...